ப்ரொஃபெஸர் ர சி து ராலிந்‌ஸந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் ர சி து ராலிந்‌ஸந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் ர சி து ராலிந்‌ஸந் Today - Breaking & Trending Today

How COVID-19 jab side effects affect your immune system

Health
by Sue Dunlevy
Premium Content
Subscriber only
Exclusive: People who experience side effects from the COVID-19 jab do not necessarily gain greater protection from the virus, nor are they more susceptible to it, experts said.
Almost half the Australians who ve had their vaccine have reported adverse reactions - and a third felt like they had the flu.
But, while it seemed logical, there was as yet no clinical evidence linking a person s severe side effects to the jab to them getting a potentially harsher version of COVID-19.
Just because you got a severe reaction to the vaccine doesn t mean you d get a severe reaction if you got the infection, although it might seem there s some logic in taking them to be related, University NSW virologist Professor Bill Rawlinson told News Corp. ....

James Croucher , Andrew Henshaw , Australian Catholic University , Exhibition Centre , News Corp , University Queensland Professor Paul Griffin , University Of Pennsylvania , Melbourne Convention , Professor Bill Rawlinson , Catholic University , Professor Paul Griffin , Bill Rawlinson , Mount Sinai Hospital , Science Immunology , Corona Virus , Covid 19 , Immune System , ஜேம்ஸ் க்ரூச்சர் , ஆண்ட்ரூ ஹென்ஷா , ஆஸ்திரேலிய கத்தோலிக் பல்கலைக்கழகம் , கண்காட்சி மையம் , செய்தி கார்ப் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , மெல்போர்ன் மாநாடு , ப்ரொஃபெஸர் ர சி து ராலிந்‌ஸந் , கத்தோலிக் பல்கலைக்கழகம் ,

New twist in COVID-19 vaccine

And, it found just a single dose of the vaccine offered considerable protection.
Three weeks after being given a single dose of the vaccine it had an efficacy rate of 76 per cent and measurements over a 90 day period showed the efficacy rate did not wane.
Vaccination programs aimed at vaccinating a large proportion of the population with a single dose, with a second dose given after a 3 month period is an effective strategy for reducing disease, and may be the optimal for rollout of a pandemic vaccine when supplies are limited in the short term, the study authors said.

The trial also confirmed the vaccine was 100 per cent effective in protecting against severe disease, hospitalisation and death. ....

United States , New South Wales , United Kingdom , South Africa , Paul Kelly , Andrew Pollard , Matt Hancock , Emma Walmsley , Oxford Astrazeneca , Franz Werner Haas , Robert Booy , Oxford Vaccine Group , World Health Organisation , News Corp , European Union , British Health , European Medicines Agency , University Sydney , Chief Medical Officer Professor Paul Kelly , Professor Bill Rawlinson , Professor Robert Booy , World Health , Health Secretary Matt Hancock , Emmanuel Macron , Oxford Vaccine , South America ,